Intratympanic injection of dexamethasone for management of labyrinthitis associated with COVID-19 disease resistant cases.

Ismaiel, Wael F; Abdelazim, Mohamed H; Wahba, Ashraf A; Alsobky, Mahmoud E; Ibrahim, Ahmed Abdalrhman; Ghanem, Soliman A; Rabaan, Ali A; Ismail, Elshahat I

Ismaiel, Wael F; Abdelazim, Mohamed H; Wahba, Ashraf A; Alsobky, Mahmoud E; Ibrahim, Ahmed Abdalrhman; Ghanem, Soliman A; Rabaan, Ali A; Ismail, Elshahat I.

Afiliação

Ismaiel WF; Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Abdelazim MH; Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Wahba AA; Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Alsobky ME; Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Ibrahim AA; Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Ghanem SA; Audiology Unit, Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Rabaan AA; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Ismail EI; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Ann Med Surg (Lond) ; 81: 104429, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35989722

Palavras-chave

COVID-19; Dexamethasone; Hearing loss; Labyrinthitis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google